On December 4, 2025, the Judicial Panel on Multidistrict Litigation (JPML) heard arguments for creating a group lawsuit for people who lost their vision after taking Mounjaro and other GLP-1 drugs
L., & Summar, M
Studies using beta-3 adrenergic receptor knockout mice confirmed the specificity of this mechanism, as these animals showed no fat loss response to AOD-9604
Theory 4: Increased sensitivity to smell In some scenarios, GLP-1 medications have been linked to an increased sensitivity to smell, says Elizabeth Hamel, a postdoctoral fellow at Monell Center with a PhD in taste and adjusted behaviors research, who has studied GLP-1 drugs
In our recent study, type 2 diabetic patients had high NEFA concentrations as well as hyperglucagonaemia, the influences of which may have balanced each other out, resulting in no net difference in GLP-1 secretory responses [25]